Skip to main content
KOLMAR KOREA CO.,LTD logo

KOLMAR KOREA CO.,LTD — Investor Relations & Filings

Ticker · 161890 ISIN · KR7161890009 KO Manufacturing
Open in API
Filings indexed 630 across all filing types
Latest filing 2020-06-19 Proxy Solicitation & In…
Country KR South Korea
Listing KO 161890

About KOLMAR KOREA CO.,LTD

https://www.kolmar.co.kr/eng/

Kolmar Korea is a leading Original Design Manufacturer (ODM) providing comprehensive platform services for the cosmetics, pharmaceutical, and health food sectors. As a pioneer in the cosmetics ODM model, the company offers an end-to-end solution for client brands, encompassing trend analysis, product planning, research and development, manufacturing, and quality control. Its extensive R&D capabilities are driven by numerous specialized laboratories focusing on areas such as skincare, makeup, personal care, UV technology, and biome research. The company develops and produces a wide range of products, from advanced skincare and color cosmetics to health supplements and pharmaceuticals, leveraging its expertise in formulation, material science, and CGMP-certified manufacturing technology.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Solicitation' (위임권유) for an Extraordinary General Meeting (임시 주주총회) of Kolmar Korea. It details the agenda for the sale of a business unit (제약 CMO 사업부), provides information on the proxy solicitor, the voting process, and the details of the business transfer (M&A/Asset Sale). While it contains M&A-related information, the primary purpose of this specific filing is to solicit proxies from shareholders for the upcoming meeting, which falls under the Proxy Solicitation & Information Statement category.
2020-06-19 Korean
단기차입금증가결정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory disclosure from Kolmar Korea regarding a decision to increase short-term borrowings through the issuance of commercial paper (CP). This falls under corporate financing activities and capital structure changes. According to the provided definitions, 'CAP' (Capital/Financing Update) is the most accurate category for updates on company fundraising and financing activities.
2020-06-16 Korean
타인에대한채무보증결정
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing from the Korean DART system regarding a 'Decision on Debt Guarantee for Others' (타인에 대한 채무보증결정) by Kolmar Korea. It details the financial guarantee provided by the parent company to its subsidiary, Kolmar Cosmetics (Wuxi) Co., Ltd., including specific amounts, creditors, and board resolution details. As this is a specific regulatory disclosure regarding corporate financial obligations that does not fit into the other specialized categories like earnings or dividends, it is classified as a general regulatory filing.
2020-06-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by the National Pension Service regarding their holdings in Kolmar Korea. This type of filing is a regulatory requirement for major shareholders to disclose changes in their equity stake. In the provided classification schema, this falls under 'Major Shareholding Notification' (MRQ), as it details the change in share ownership levels by a major shareholder.
2020-06-03 Korean
기업지배구조보고서공시
Governance Information Classification · 100% confidence The document is titled 'Corporate Governance Report' (기업지배구조 보고서) for Kolmar Korea. It outlines the company's governance policies, board structure, shareholder rights, and audit mechanisms in accordance with regulatory disclosure requirements. Since it details the internal rules, board structure, and governance practices of the company, it falls under the 'Governance Information' category.
2020-06-01 Korean
주요사항보고서(영업양도결정)
M&A Activity Classification · 100% confidence The document is a formal 'Major Business Report' (주요사항보고서) filed with the Financial Services Commission and the Korea Exchange. It details a 'Decision on Business Transfer' (영업양도 결정), specifically the sale of the pharmaceutical business division of Kolmar Korea. This type of filing, which involves the sale of a business unit, is classified under M&A Activity (TAR) as it pertains to corporate restructuring and asset divestiture.
2020-05-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.